Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Godschalk, R. W.L.
Right arrow Articles by Van Schooten, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Godschalk, R. W.L.
Right arrow Articles by Van Schooten, F. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 1, 87-92, January 2000
© 2000 Oxford University Press


Carcinogenesis

Exposure-route-dependent DNA adduct formation by polycyclic aromatic hydrocarbons

Roger W.L. Godschalk1, Edwin J.C. Moonen, Pauline A.E.L. Schilderman, Wendy M.R. Broekmans2, Jos C.S. Kleinjans and Frederik J. Van Schooten3

Department of Health Risk Analysis and Toxicology, Maastricht University, Universiteitssingel 50, PO Box 616, 6200 MD, Maastricht, The Netherlands

Understanding the kinetics of aromatic–DNA adducts in target tissues and white blood cells (WBC) would enhance the applicability of DNA adducts in WBC as surrogate source of DNA in biomonitoring studies. In the present study, rats were acutely exposed to benzo[a]pyrene (B[a]P; 10 mg/kg body wt) via intratracheal (i.t.), dermal and oral administration. DNA adducts were analyzed in relevant target organs and WBC by nuclease P1 enriched 32P-post-labeling at 1, 2, 4, 11 and 21 days after exposure. Additionally, the internal dose was assessed by measurement of urinary excretion of 3-hydroxy-B[a]P (3-OH-B[a]P). Total B[a]P–DNA adduct levels in WBC were highest after i.t. and oral administration, whereas DNA adducts were hardly detectable after dermal exposure. Highest adduct levels were reached at 2 days after exposure. In lung tissue, DNA adduct levels reached maximal values at 2 days and were highest after i.t., oral and dermal exposure, respectively. DNA adduct levels were significantly lower in WBC as compared with lung. Nonetheless, overall B[a]P–DNA adduct levels in WBC were significantly correlated with those in lung. In target organs, highest DNA adduct levels were observed in skin after topical application, and lowest in stomach after oral administration of B[a]P. Furthermore, DNA adduct levels in WBC were correlated with DNA adduct levels in skin after dermal exposure and stomach after oral administration of B[a]P. Two-fold higher levels of 3-OH-B[a]P were excreted after i.t. administration of B[a]P as compared with dermal or oral exposure. Urinary 3-OH-B[a]P concentrations were correlated with DNA adduct levels at the site of B[a]P application. Overall, it can be concluded that aromatic–DNA adduct levels in WBC can be applied as a surrogate source of DNA for the site of application of B[a]P and reflect binding to lung DNA, independently of the exposure route.

Abbreviations: 3-OH-B[a]P, 3-hydroxy-benzo[a]pyrene; B[a]P, benzo[a]pyrene; i.t., intratracheal instillation; NP1, nuclease P1; PAHs, polycyclic aromatic hydrocarbons; WBC, white blood cells.

1 Present address: Department of Toxicology and Cancer Risk Factors, German Cancer Research Center, PO Box 101949, D-69009 Heidelberg, Germany

2 Present address: Department of Physiology, TNO Voeding, 3700 AJ, Zeist, The Netherlands

3 To whom correspondence should be addressed Email: f.vanschooten{at}grat.unimaas.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
L. C. Wilms, A. W. Boots, V. C.J. de Boer, L. M. Maas, D. M.F.A. Pachen, R. W.H. Gottschalk, H. B. Ketelslegers, R. W.L. Godschalk, G. R.M.M. Haenen, F. J. van Schooten, et al.
Impact of multiple genetic polymorphisms on effects of a 4-week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in human volunteers
Carcinogenesis, August 1, 2007; 28(8): 1800 - 1806.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. A. Bieler, M. G. Cornelius, M. Stiborova, V. M. Arlt, M. Wiessler, D. H. Phillips, and H. H. Schmeiser
Formation and persistence of DNA adducts formed by the carcinogenic air pollutant 3-nitrobenzanthrone in target and non-target organs after intratracheal instillation in rats
Carcinogenesis, May 1, 2007; 28(5): 1117 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
D. M. van Leeuwen, R. W. H. Gottschalk, M. H. van Herwijnen, E. J. Moonen, J. C. S. Kleinjans, and J. H. M. van Delft
Differential Gene Expression in Human Peripheral Blood Mononuclear Cells Induced by Cigarette Smoke and Its Constituents
Toxicol. Sci., July 1, 2005; 86(1): 200 - 210.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Godschalk, J. Nair, F.J. van Schooten, A. Risch, P. Drings, K. Kayser, H. Dienemann, and H. Bartsch
Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking
Carcinogenesis, December 1, 2002; 23(12): 2081 - 2086.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. P. Perera, L. A. Mooney, M. Stampfer, D. H. Phillips, D. A. Bell, A. Rundle, S. Cho, W.-Y. Tsai, J. Ma, A. Blackwood, et al.
Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study
Carcinogenesis, October 1, 2002; 23(10): 1641 - 1646.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al.
Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study
Cancer Res., September 1, 2001; 61(18): 6708 - 6712.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
H. Helleberg, H. Xu, L. Ehrenberg, K. Hemminki, U. Rannug, and M. Tornqvist
Studies of dose distribution, premutagenic events and mutation frequencies for benzo[a]pyrene aiming at low dose cancer risk estimation
Mutagenesis, July 1, 2001; 16(4): 333 - 337.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Hainaut and G. P. Pfeifer
Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke
Carcinogenesis, March 1, 2001; 22(3): 367 - 374.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.